Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuwen Guan

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Cancer Innovation|December 13, 2023
Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancerXiuwen Guan, Fei Ma, Binghe Xu
Cancer Innovation|October 21, 2024
Development and validation of the NCC-BC-A scale to assess patient-reported outcomes for breast cancer patients in ChinaFei Ma, Xiaoyan Yan, Xiuwen Guan, et al.
Molecular and Clinical Oncology|August 8, 2017
Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysisZongbi Yi, Binliang Liu, Xiuwen Guan, et al.
Topics in Current Chemistry (Cham)|March 11, 2017
Peptide-Based and Polypeptide-Based Gene Delivery SystemsJie Chen, Xiuwen Guan, Yingying Hu, et al.
Anti-Cancer Drugs|February 13, 2016
Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer: a meta-analysisHaili Qian, Haijuan Wang, Xiuwen Guan, et al.
Breast Cancer Research and Treatment|April 23, 2017
The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysisBinliang Liu, Zongbi Yi, Xiuwen Guan, et al.
Anti-Cancer Drugs|June 19, 2015
Platinum-based chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis of randomized-controlled trialsXiuwen Guan, Fei Ma, Ying Fan, et al.
Medicine|March 18, 2016
The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA GuidelinesXiuwen Guan, Haijuan Wang, Fei Ma, et al.
Nano Letters|September 20, 2016
Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery SystemXiuwen Guan, Zhaopei Guo, Lin Lin, et al.
Journal of Oncology|December 10, 2021
Breast Cancer in Chinese Females Aged 25 Years and YoungerLixi Li, Dan Lv, Jingtong Zhai, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Cancer Innovation|December 13, 2023
Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancerXiuwen Guan, Fei Ma, Binghe Xu
Cancer Innovation|October 21, 2024
Development and validation of the NCC-BC-A scale to assess patient-reported outcomes for breast cancer patients in ChinaFei Ma, Xiaoyan Yan, Xiuwen Guan, et al.
Molecular and Clinical Oncology|August 8, 2017
Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysisZongbi Yi, Binliang Liu, Xiuwen Guan, et al.
Topics in Current Chemistry (Cham)|March 11, 2017
Peptide-Based and Polypeptide-Based Gene Delivery SystemsJie Chen, Xiuwen Guan, Yingying Hu, et al.
Anti-Cancer Drugs|February 13, 2016
Adoptive immunotherapy combined chemoradiotherapy for non-small-cell lung cancer: a meta-analysisHaili Qian, Haijuan Wang, Xiuwen Guan, et al.
Breast Cancer Research and Treatment|April 23, 2017
The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysisBinliang Liu, Zongbi Yi, Xiuwen Guan, et al.
Anti-Cancer Drugs|June 19, 2015
Platinum-based chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis of randomized-controlled trialsXiuwen Guan, Fei Ma, Ying Fan, et al.
Medicine|March 18, 2016
The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA GuidelinesXiuwen Guan, Haijuan Wang, Fei Ma, et al.
Nano Letters|September 20, 2016
Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery SystemXiuwen Guan, Zhaopei Guo, Lin Lin, et al.
Journal of Oncology|December 10, 2021
Breast Cancer in Chinese Females Aged 25 Years and YoungerLixi Li, Dan Lv, Jingtong Zhai, et al.
Pageof 7